Improving HIV counseling through an educational app about undetectable viral loads.
Official title: Integrating U=U into HIV counseling: a cluster-randomized efficacy trial (INTUIT 2.0)
Funded at Boston University Medical Campus · NIH-10925871 · Data updated 2026-11-12
This study is testing a helpful app called 'Undetectable & You' that teaches people living with HIV about the idea that if their viral load is undetectable, they can't pass on the virus, and it aims to see if using the app can help them stick to their treatment and stay healthy in South Africa.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 13, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $636,301 |
| NIH project number | 1R01MH135774-01A1 |
| Project ID | NIH-10925871 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV in South Africa who are seeking to understand their treatment options and improve their health.
✕Less likely to help
Patients who are not living with HIV or those who are not engaged in HIV care may not receive any benefit from this research.
What this research studies
This research focuses on enhancing HIV counseling by integrating the concept of 'Undetectable = Untransmittable' (U=U) into patient education. It involves refining an educational app called 'Undetectable & You,' which was co-created with people living with HIV and healthcare providers. The app shares personal stories and scientific information to help patients understand that if their viral load is undetectable, they cannot transmit HIV. The study will evaluate the app's effectiveness in improving adherence to antiretroviral therapy (ART) and achieving viral suppression among participants in South Africa.
Why it matters
Potential benefit: If successful, this research could empower patients with HIV by reducing stigma and improving their health outcomes through better adherence to treatment.
How similar studies have gone: Previous research has shown that educational interventions like U=U can significantly improve knowledge and health outcomes among people living with HIV, indicating a promising approach.
Where this research is happening
-
Boston University Medical Campus
Boston, United States Active
Researchers
- Principal investigator: Bor, Jacob — Boston University Medical Campus
- Study coordinator: Bor, Jacob
Related research
Other NIH-funded projects on the same topics.
-
Creating a detailed map of early lung cancer changes
This study is looking at early changes in lung tissue that can lead to cancer, specifically focusing on common types of lung cancer, and it's for patients who want to help researchers understand these changes better so they can improve early detection and treatment.
-
Telomere trouble in ALT cancers: what causes damage and how it happens
Researchers are studying why some cancer cells use ALT to lengthen telomeres and how replication stress damages telomeres, aiming to uncover key processes that could be targeted in patients.
-
IL-6 signaling, lung injury, and post-TB lung disease in TB/HIV
This grant tests how a specific immune signal (IL-6) relates to lung damage after tuberculosis in people with and without HIV, aiming to understand who is at risk for lasting lung problems.
-
IL-6 signaling and lung injury after TB and HIV co-infection
This project looks at how a common immune signal called IL-6 relates to lung injury after TB treatment, especially in people who also have HIV.
-
LEAD Africa: advancing Alzheimer’s research across Africa
A new project aims to build Alzheimer’s disease research capabilities in Africa to improve understanding and care for people with dementia.
-
Leading AD and related dementias research in Africa
A multi-country effort aims to build Africa’s capacity to study Alzheimer’s disease and related dementias using scalable, low-cost methods.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.